Huntington Medical Research Institutes

New Guidelines on Men with Erectile Dysfunction and Cardiac Health Published in the Journal of Sexual Medicine Concludes PDE-5 Inhibitors are Still Safe for the Cardiovascular System

Retrieved on: 
Thursday, January 4, 2024
Research, Seniors, Men, Cardiology, Biotechnology, Health, Consumer, Pharmaceutical, Science, Patient, Exercise, HMRI, ED, Risk, Nitrate, Woman, PDE5, Hypotension, Moyamoya disease, B cell, Mortality, Regenerative medicine, Pharmacist, Platelet-rich plasma, MBA, MD, Doctor of Philosophy, Huntington Medical Research Institutes, Pulmonary hypertension, Tadalafil, University, CVD, Death, CAC, System, CT scan, Oxygen, American College, Contra, Overalls, Dietary supplement, Princeton University, Ischemia, Journal, Female, Johns Hopkins, Erectile dysfunction, Pharmaceutical industry

Their summary and guidelines have now been published in the Journal of Sexual Medicine.

Key Points: 
  • Their summary and guidelines have now been published in the Journal of Sexual Medicine.
  • They determined that PDE-5 inhibitors are still safe for the cardiovascular system.
  • The conference was funded by an unrestricted grant from Sanofi to readdress the cardiovascular workup of men presenting with ED and the cardiovascular safety of the phosphodiesterase-5 (PDE-5) inhibitors for treating ED.
  • Patients with ED should be characterized as low-risk, intermediate (or indeterminable), or high-risk of developing a cardiac event with sexual activity.

Annual Congress 2023 of the European Academy of Allergy and Clinical Immunology: Groundbreaking Study Validates Allergen Exposure Chamber for Assessing Clinical Outcomes of HDM AIT in Allergic Rhinoconjunctivitis Patients'

Retrieved on: 
Sunday, June 11, 2023
AIT, HDM, Huntington Medical Research Institutes, Wrocław Medical University, VAS, Visual analogue scale, Conjunctivitis, Patient, AEC, Immunoglobulin E, Safety, Medical imaging

The study focused on evaluating the efficacy and safety of AEC-derived clinical outcomes of subcutaneous HDM AIT, a treatment designed to alleviate symptoms triggered by HDM allergies.

Key Points: 
  • The study focused on evaluating the efficacy and safety of AEC-derived clinical outcomes of subcutaneous HDM AIT, a treatment designed to alleviate symptoms triggered by HDM allergies.
  • Fifty patients with HDM-triggered allergic rhinoconjunctivitis were included in the study, with HDM allergy confirmed through various diagnostic tests such as skin prick tests, serum-specific IgE, and basophil activation tests.
  • During the study, patients were assessed in the allergen exposure chamber before commencing AIT and after 12 months of treatment.
  • The chamber provided a controlled environment, allowing patients to be exposed to HDM allergen under stable and well-regulated conditions.

HMRI Appoints Two New Members to Board of Directors

Retrieved on: 
Monday, April 24, 2023
Health, Other Health, Other Science, General Health, Research, Science, Biotechnology, USC Marshall School of Business, University, PwC, Education, Liver disease, Fatty liver disease, Business, Biomedical Research, American Liver Foundation, Private practice, Liver cancer, Organization, Huntington Medical Research Institutes, Business administration, Patient, Health care, HMRI, Cooper, Master of Business Administration, Management

Huntington Medical Research Institutes (HMRI), a leading biomedical research organization in Southern California with a 70-year track record of impact, announced it added Dr. Edward Mena and accountant Rick Wentzel to its board of directors.

Key Points: 
  • Huntington Medical Research Institutes (HMRI), a leading biomedical research organization in Southern California with a 70-year track record of impact, announced it added Dr. Edward Mena and accountant Rick Wentzel to its board of directors.
  • “We are thrilled to welcome Edward and Rick to our board of directors,” Dr. Julia Bradsher, president and CEO of HMRI, said.
  • He previously worked at the HMRI Liver Center and later opened his own private practice and research facility focused on liver disease.
  • Mena and Wentzel join the distinguished HMRI Board of Directors , led by Board Chair Dr. Susan E. Kane.

HMRI Celebrates Women’s History Month: ‘Women have been at the forefront of our most groundbreaking research for decades’

Retrieved on: 
Monday, March 20, 2023
Health, Philanthropy, General Health, Women, Other Philanthropy, Other Science, Research, Foundation, Consumer, Science, Clinical Trials, Epilepsy, Psychiatry, Tissue, Heart, City of Hope National Medical Center, Male, Mechanics, Depression, Life, In vivo magnetic resonance spectroscopy, Schizophrenia, Culture, Public, Henry Purcell, Workplace, 3D, Anxiety, SURF, DSM-IV codes, Injury, Biomedical Research, Woman, Brain, Mentorship, History, Huntington Medical Research Institutes, MRI, Hydrocephalus, Student, City, NASA, Engineering, HMRI, STEM, Biology, Faculty, Environment, Family, Female, Dr B C Roy Institute of Medical Sciences & Research, Nursing, Management, Medical imaging

Women are and have been at the forefront of our most groundbreaking research for decades.

Key Points: 
  • Women are and have been at the forefront of our most groundbreaking research for decades.
  • Dr. Marylou Ingram, one of the most influential women scientists at HMRI, was a senior research scientist when she arrived in 1982.
  • Through a bequest, Ingram endowed the Marylou Ingram Chair in Medical Science Research, ensuring future HMRI researchers would have the resources to be as groundbreaking as she was.
  • Dr. Julia Bradsher is a successful scientist, strategic leader and the dynamic CEO of HMRI, directing the institute in its focused growth strategy.

Milestone Study Exploring the Significant Impact of ED Drugs on Men’s Cardiac Health Published in the Journal of Sexual Medicine

Retrieved on: 
Tuesday, January 17, 2023
Research, Men, Cardiology, Health, Consumer, Pharmaceutical, General Health, Other Science, Science, University of California, San Francisco, ED, Cardiovascular disease, Sildenafil, HMRI, University, Record, Tadalafil, Death, Angioplasty, MD, Huntington Medical Research Institutes, MACE, Medicare, Manuscript, Risk, Diabetes, Mortality, Heart failure, Vardenafil, Unstable angina, Degenerative disease, PDE5, Doctor of Philosophy, Keck School of Medicine of USC, Erectile dysfunction, Pharmaceutical industry, Sanofi, Medicine

This study marks a significant medical milestone, as it’s the first time the association between the use of PDE-5i drugs and cardiovascular health has been explored in a large population of relatively low-risk men with ED in the United States.

Key Points: 
  • This study marks a significant medical milestone, as it’s the first time the association between the use of PDE-5i drugs and cardiovascular health has been explored in a large population of relatively low-risk men with ED in the United States.
  • In this study, scientists analyzed health records of more than 70,000 men with ED.
  • The study, funded by a grant from Sanofi , examined records over approximately 14 years.
  • The overall benefit in reduction of cardiac events was observed in men who also had risk factors for cardiovascular disease including diabetes.

Huntington Medical Research Institutes to Host Holiday Open House Commemorating 70th Anniversary

Retrieved on: 
Friday, December 2, 2022
Women, Seniors, Other Health, Men, Research, Children, Family, Mental Health, Medical Devices, Consumer, Science, Cardiology, General Health, Biotechnology, Neurology, Health, COVID-19, Other Education, Education, Prostate cancer, Student, Learning, Medicine, Biomedical Research, COVID-19, Huntington Hospital, Health, Huntington Medical Research Institutes, MBA, Brain, Heart, Research, Hydrocephalus, Malaghan Institute of Medical Research, Degenerative disease, MRI, HMRI, Retractions in academic publishing, Journal of Head Trauma Rehabilitation, Patient, Medical research, Multimedia, Migraine, Hospital, Science, Doctor of Philosophy, Microwave spectroscopy, Medical device, Management, Medical imaging, Kristin Pudenz

Huntington Medical Research Institutes (HMRI), a leading biomedical research organization in Southern California, is celebrating its 70th anniversary by opening its doors to the public this Saturday, December 3, 2022, from 11 a.m. to 3 p.m. for its Holiday Open House.

Key Points: 
  • Huntington Medical Research Institutes (HMRI), a leading biomedical research organization in Southern California, is celebrating its 70th anniversary by opening its doors to the public this Saturday, December 3, 2022, from 11 a.m. to 3 p.m. for its Holiday Open House.
  • We look forward to celebrating many more innovative discoveries in our focus areas of cardiovascular, neurovascular and neuroscience research.
  • HMRI began as an outgrowth of two separate institutes: Pasadena Foundation for Medical Research, established in 1952, and the Institute of Medical Research of Huntington Memorial Hospital, founded in 1953.
  • Huntington Medical Research Institutes (HMRI) is an independent, nonprofit organization located in Pasadena, California.

Huntington Medical Research Institutes Welcomes New Chief Financial Officer

Retrieved on: 
Thursday, September 1, 2022
Medical Devices, Health, Other Science, Research, Cardiology, Science, Laser, 94th Academy Awards, Rincon, Degenerative disease, Lists of diseases, Research, Migraine, Budget, Doctor of Philosophy, Brain, Academy of Motion Picture Arts and Sciences, Solution, Science, Huntington Medical Research Institutes, Academy, Heart, Multimedia, Method, CFO, MBA, HMRI, Demographics of Los Angeles, Neoplasm, Kiewit, Growth, Patient, Hospital, Management, Medical imaging, Pharmaceutical industry

Huntington Medical Research Institutes (HMRI), an independent, nonprofit medical research organization in Southern California, has appointed Gabriel Rincon as the companys chief financial officer and treasurer, effective July 2022.

Key Points: 
  • Huntington Medical Research Institutes (HMRI), an independent, nonprofit medical research organization in Southern California, has appointed Gabriel Rincon as the companys chief financial officer and treasurer, effective July 2022.
  • View the full release here: https://www.businesswire.com/news/home/20220901005643/en/
    HMRI welcomes Gabriel Rincon as chief financial officer and treasurer, effective July 2022.
  • As HMRIs chief financial officer, Rincon directs the organizations accounting practices, budgeting and financial analysis, financial records and reports, and regulatory compliance, among other responsibilities.
  • Huntington Medical Research Institutes (HMRI) is an independent, nonprofit organization located in Pasadena, California.

Huntington Medical Research Institutes Present First-of-its-Kind Study Examining Impact of Erectile Dysfunction Drugs on Major Adverse Cardiovascular Events and Mortality

Retrieved on: 
Friday, May 13, 2022
Science, Cardiology, Biotechnology, Research, Pharmaceutical, Men, Health, Consumer, Placebo, MBA, Death, Lists of diseases, ED, Huntington Medical Research Institutes, Population, HMRI, Nationwide Mutual Insurance Company, Tadalafil, Degenerative disease, Doctor of Philosophy, Patient, Migraine, American Heart Association, Solution, Association, Causality, Sildenafil, University of California, San Francisco, American Heart, Vardenafil, Medicare, San Francisco, Research, Erectile dysfunction, Brain, Man, University, Heart failure, Mortality, Heart, Care, Unstable angina, Tablet, Coronary artery disease, Angioplasty, Record, MD, CEO, Pharmaceutical industry, Dietary supplement, Sanofi

Scientists from Huntington Medical Research Institutes (HMRI) in Pasadena, HealthCore Inc. and the University of California San Francisco analyzed health records of more than 70,000 men with ED.

Key Points: 
  • Scientists from Huntington Medical Research Institutes (HMRI) in Pasadena, HealthCore Inc. and the University of California San Francisco analyzed health records of more than 70,000 men with ED.
  • They compared rates of major adverse cardiovascular events (MACE) and death amongst men who took phosphodiesterase type 5 inhibitor (PDE-5i) drugsincluding Viagra, Cialis and Levitrato rates among men who never took these drugs.
  • Since the study was retrospective, Kloner noted that further research is needed to prove that PDE-5i drugs caused the reduction in cardiovascular events that he and his co-investigators observed.
  • Huntington Medical Research Institutes (HMRI) works to improve millions of lives through patient-focused scientific research.

Systemic Therapeutics Uncovers the Protective Mechanism of Caffeine Against Cardiovascular Disease

Retrieved on: 
Wednesday, February 9, 2022
Nature Communications, Libin Cardiovascular Institute of Alberta, Kilimanjaro Clinical Research Institute, Department, McMaster University, NASH, Company, PCSK9, Cholesterol, Systemic, LDL, Therapy, Risk, Fatty liver disease, Patient, University, Time-invariant system, Caffeine, Liver, Blood, Lists of diseases, SREBP, Cardiovascular disease, Drug discovery, Huntington Medical Research Institutes, Kidney, Diabetes, Lipid metabolism, Hamilton Centre, Dyslipidemia, Pharmaceutical industry, Dietary supplement

(the "Company" or "SystemicTx") have a new understanding of the protective effects of caffeine on the cardiovascular system.

Key Points: 
  • (the "Company" or "SystemicTx") have a new understanding of the protective effects of caffeine on the cardiovascular system.
  • While its stimulant effects have long been characterized, a team of Canadian researchers have discovered how caffeine interacts with key cellular factors to remove cholesterol from the bloodstream.
  • Elevated levels of LDL cholesterol are associated with increased risk of cardiovascular disease.
  • "These findings now provide the underlying mechanism by which caffeine and its derivatives can mitigate the levels of blood PCSK9 and thereby reduce the risk of cardiovascular disease," said Austin, senior author of the study.